These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 8907129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G, Pieske B, Kretschmann B, Holubarsch C, Alpert NR, Just H.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A, Papp JG, Udvary E, Kaszala K.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Will calcium sensitizers play a role in the treatment of heart failure?
    Nielsen-Kudsk JE, Aldershvile J.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M, Lehtonen L, Nieminen MS.
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract] [Full Text] [Related]

  • 16. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
    Müller-Ehmsen J, Nickel J, Zobel C, Hirsch I, Bölck B, Brixius K, Schwinger RH.
    Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
    [Abstract] [Full Text] [Related]

  • 17. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole.
    Achenbach C, Ziskoven R, Wiemer J, Hauswirth O.
    Arzneimittelforschung; 1984 Mar; 34(11):1498-506. PubMed ID: 6543125
    [Abstract] [Full Text] [Related]

  • 18. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M.
    J Cardiovasc Pharmacol; 1995 Mar; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [Abstract] [Full Text] [Related]

  • 19. Negative lusitropy and abnormal calcium handling in hypoxic cardiac myocytes exposed to the calcium-sensitizer EMD 53998.
    Webster KA, Bodi I, McNamara JP, Tracy M, Discher DJ, Bishopric NH.
    J Mol Cell Cardiol; 1993 Jul; 25(7):747-51. PubMed ID: 8230239
    [Abstract] [Full Text] [Related]

  • 20. Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: role of calcium overload.
    Ruch SR, Nishio M, Wasserstrom JA.
    J Pharmacol Exp Ther; 2003 Oct; 307(1):419-28. PubMed ID: 12954807
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.